NCT03970083View on ClinicalTrials.gov

A Pilot Study of Quantitative Tumor Oxygen Measurements in Cervical Cancer

Active, not recruitingOBSERVATIONAL
Enrollment

10

Participants

Timeline

Start Date

July 16, 2019

Primary Completion Date

March 30, 2020

Study Completion Date

September 30, 2025

Conditions
Gynecologic CancerCervical Cancer
Trial Locations (1)

02115

Brigham and Women's Hospital, Boston

All Listed Sponsors
lead

Dana-Farber Cancer Institute

OTHER

NCT03970083 - A Pilot Study of Quantitative Tumor Oxygen Measurements in Cervical Cancer | Biotech Hunter | Biotech Hunter